Stocks
Eton Pharmaceuticals, Inc.ETON
NASDAQHealthcarePharmaceuticals$49.22
Price as of · delayed, not real-time
A specialty pharmaceutical company focused on developing and commercializing products for pediatric and other niche therapeutic areas. Its lead product, EDSIVO, treats a rare form of high blood pressure in the lungs, and it has a pipeline of additional drug candidates. Investors track ETON for its commercial-stage revenue growth and potential FDA approvals.
52W Range: $14.27-$66.37
Congressional Interest in Eton Pharmaceuticals, Inc. (ETON)
1 member of Congress has disclosed 1 trade in Eton Pharmaceuticals, Inc. (ETON), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading ETON?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-10-26 | KENNY MARCHANT | buy | $1K-$15K |